Lantheus Holdings (LNTH) Financial Analysis & Valuation | Quarter Chart

Lantheus Holdings (LNTH)

LNTH
Price: $109.58
Fair Value: 🔒
🔒score
Lantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in the diagnosis and treatment of heart, cancer, and other diseases worldwide. It provides DEFINITY, a microbubble ultrasound enhancing agent used in ultrasound exams of the ... more
Lantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic and therapeutic produc... more
Description Shares
Market Cap$7.13BExchangeNASDAQ
SectorHealthcareIndustryDrug Manufacturers - Specialty & Generic
CountryUSCEOMary Anne Heino
IPO Date2015-06-25CAGR0.11%
Employees808Websitewww.lantheus.com
Div. Yield—Payout Ratio—
Buy Back Yield4.01%Total Yield4.01%
LNTH chart loading...
Fundamentals Technicals
Enterprise Value$4.96BP/E Ratio18.36
Forward P/E17.16PEG Ratio0.34
P/S Ratio4.83P/B Ratio6.13
P/CF Ratio18.24P/FCF Ratio20.12
EPS$5.97EPS Growth 1Y17.9%
EPS Growth 3Y—EPS Growth 5Y—
Revenue Growth 1Y0.62%Gross Margin0.6%
Operating Margin0.19%Profit Margin0.18%
ROE0.24%ROA0.12%
ROCE0.14%Current Ratio2.83
Quick Ratio2.64Cash Ratio1.5
Debt/Equity0Interest Coverage14.64
Altman Z Score5.72Piotroski Score6

View Lantheus Holdings financial charts →